Symbols / KZR Stock $7.29 +0.00% Kezar Life Sciences, Inc.

Healthcare • Biotechnology • United States • NCM
KZR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Dr. Christopher J. Kirk Ph.D.
Exch · Country NCM · United States
Market Cap 53.86M
Enterprise Value -15.81M
Income -56.03M
Sales —
FCF (ttm) -29.15M
Book/sh 9.56
Cash/sh 9.75
Employees 9
Insider 10d —
IPO Jun 21, 2018
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -1.56
PEG —
P/S —
P/B 0.76
P/C —
EV/EBITDA 0.31
EV/Sales —
Quick Ratio 11.23
Current Ratio 11.52
Debt/Eq 3.32
LT Debt/Eq —
EPS (ttm) -6.17
EPS next Y -4.66
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-12
Earnings (prior) 2026-05-11
ROA -29.52%
ROE -59.93%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 7.39M
Shs Float 5.16M
Insider Own 15.78%
Instit Own 61.26%
Short Float 2.10%
Short Ratio 1.31
Short Interest 151.60K
52W High 7.55
vs 52W High -3.44%
52W Low 3.53
vs 52W Low 106.52%
Beta 0.41
Impl. Vol. 6.25%
Rel Volume 7.01
Avg Volume 87.92K
Volume 616.01K
Target (mean) $6.00
Tgt Median $6.00
Tgt Low $5.00
Tgt High $7.00
# Analysts 2
Recom None
Prev Close $7.29
Price $7.29
Change 0.00%
About

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.00
Mean price target
2. Current target
$7.29
Latest analyst target
3. DCF / Fair value
$-71.03
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$7.29
Low
$5.00
High
$7.00
Mean
$6.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-10-17 down Jefferies Buy → Hold $7
2025-10-17 down William Blair Outperform → Market Perform —
2025-10-17 main Wells Fargo Equal-Weight → Equal-Weight $5
2025-07-16 reit HC Wainwright & Co. Neutral → Neutral —
2024-12-19 main Wells Fargo Equal-Weight → Equal-Weight $9
2024-12-02 reit HC Wainwright & Co. Neutral → Neutral —
2024-11-14 main Wells Fargo Equal-Weight → Equal-Weight $11
2024-10-18 reit HC Wainwright & Co. — → Neutral —
2024-10-14 reit HC Wainwright & Co. — → Neutral —
2024-10-02 down HC Wainwright & Co. Buy → Neutral —
2024-08-14 reit HC Wainwright & Co. Buy → Buy $7
2024-07-22 main HC Wainwright & Co. Buy → Buy $7
2024-05-10 reit HC Wainwright & Co. Buy → Buy $20
2024-03-15 reit HC Wainwright & Co. Buy → Buy $20
2023-12-04 reit HC Wainwright & Co. Buy → Buy $20
2023-11-27 reit HC Wainwright & Co. Buy → Buy $20
2023-11-14 main Wells Fargo Equal-Weight → Equal-Weight $2
2023-10-12 reit HC Wainwright & Co. Buy → Buy $20
2023-10-05 down JonesTrading Buy → Hold —
2023-09-25 main HC Wainwright & Co. Buy → Buy $20
News
RSS: Latest KZR news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-07-02 SCHILLER MARK C Chief Operating Officer — 561 $4.28 $2,401
2025-07-02 CHIANG PICHI LUO Officer — 264 $4.28 $1,130
2024-07-02 SCHILLER MARK C Officer — 6,688 $0.58 $3,879
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
-100.00%
7.00
0.00
Operating Revenue
0.00
0.00
-100.00%
7.00
0.00
Operating Expense
52.27
-41.36%
89.14
-20.58%
112.24
+57.72%
71.16
Research And Development
33.76
-48.65%
65.74
-23.29%
85.70
+68.00%
51.01
Selling General And Administration
18.51
-20.86%
23.39
-11.86%
26.54
+31.69%
20.15
General And Administrative Expense
18.51
-20.86%
23.39
-11.86%
26.54
+31.69%
20.15
Other Gand A
18.51
-20.86%
23.39
-11.86%
26.54
+31.69%
20.15
Total Expenses
52.27
-41.36%
89.14
-20.58%
112.24
+57.72%
71.16
Operating Income
-52.27
+41.36%
-89.14
+15.30%
-105.24
-47.88%
-71.16
Total Operating Income As Reported
-59.11
+34.76%
-90.61
+18.68%
-111.42
-56.58%
-71.16
EBITDA
-53.77
+33.71%
-81.10
+18.29%
-99.25
-50.31%
-66.03
Normalized EBITDA
-46.93
+41.07%
-79.63
+14.43%
-93.07
-40.94%
-66.03
Reconciled Depreciation
0.90
-13.75%
1.04
-2.44%
1.07
+4.20%
1.02
EBIT
-54.66
+33.45%
-82.14
+18.12%
-100.32
-49.61%
-67.05
Total Unusual Items
-6.84
-365.10%
-1.47
+76.24%
-6.19
0.00
Total Unusual Items Excluding Goodwill
-6.84
-365.10%
-1.47
+76.24%
-6.19
0.00
Special Income Charges
-6.84
-365.10%
-1.47
+76.24%
-6.19
0.00
Restructuring And Mergern Acquisition
5.74
+7367.09%
-0.08
-102.41%
3.28
0.00
Write Off
1.10
-29.24%
1.55
-46.73%
2.91
—
Net Income
-56.03
+33.08%
-83.74
+17.80%
-101.87
-49.28%
-68.24
Pretax Income
-56.03
+33.08%
-83.74
+17.80%
-101.87
-49.28%
-68.24
Net Non Operating Interest Income Expense
3.07
-55.25%
6.87
-28.10%
9.55
+226.86%
2.92
Interest Expense Non Operating
1.37
-14.00%
1.59
+2.77%
1.55
+30.80%
1.19
Net Interest Income
3.07
-55.25%
6.87
-28.10%
9.55
+226.86%
2.92
Interest Expense
1.37
-14.00%
1.59
+2.77%
1.55
+30.80%
1.19
Interest Income Non Operating
4.44
-47.48%
8.46
-23.79%
11.10
+170.30%
4.11
Interest Income
4.44
-47.48%
8.46
-23.79%
11.10
+170.30%
4.11
Other Income Expense
-6.84
-365.10%
-1.47
+76.24%
-6.19
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-56.03
+33.08%
-83.74
+17.80%
-101.87
-49.28%
-68.24
Net Income From Continuing Operation Net Minority Interest
-56.03
+33.08%
-83.74
+17.80%
-101.87
-49.28%
-68.24
Net Income From Continuing And Discontinued Operation
-56.03
+33.08%
-83.74
+17.80%
-101.87
-49.28%
-68.24
Net Income Continuous Operations
-56.03
+33.08%
-83.74
+17.80%
-101.87
-49.28%
-68.24
Normalized Income
-49.20
+40.20%
-82.27
+14.02%
-95.68
-40.22%
-68.24
Net Income Common Stockholders
-56.03
+33.08%
-83.74
+17.80%
-101.87
-49.28%
-68.24
Diluted EPS
-7.66
+30.36%
-11.00
+21.65%
-14.04
-39.01%
-10.10
Basic EPS
-7.66
+30.36%
-11.00
+21.65%
-14.04
-39.01%
-10.10
Basic Average Shares
7.32
+0.37%
7.29
+0.48%
7.26
+7.70%
6.74
Diluted Average Shares
7.32
+0.37%
7.29
+0.48%
7.26
+7.70%
6.74
Diluted NI Availto Com Stockholders
-56.03
+33.08%
-83.74
+17.80%
-101.87
-49.28%
-68.24
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
76.65
-47.02%
144.68
-34.60%
221.24
-26.15%
299.57
Current Assets
75.73
-44.92%
137.49
-33.56%
206.95
-27.57%
285.72
Cash Cash Equivalents And Short Term Investments
71.88
-45.65%
132.25
-34.33%
201.37
-27.19%
276.56
Cash And Cash Equivalents
71.88
+72.17%
41.75
+17.63%
35.49
-12.27%
40.46
Cash Equivalents
—
41.14
+16.38%
35.35
—
Cash Financial
—
0.61
+322.92%
0.14
—
Other Short Term Investments
0.00
-100.00%
90.50
-45.44%
165.88
-29.74%
236.10
Receivables
2.00
+112.90%
0.94
-66.46%
2.80
—
Other Receivables
1.81
+252.72%
0.51
-75.55%
2.10
—
Accrued Interest Receivable
0.18
-56.60%
0.42
-38.99%
0.69
—
Prepaid Assets
1.14
-71.24%
3.95
+56.28%
2.53
-72.38%
9.16
Assets Held For Sale Current
0.52
0.00
—
—
Other Current Assets
0.20
-43.02%
0.35
+39.84%
0.25
-72.72%
0.92
Total Non Current Assets
0.92
-87.28%
7.19
-49.64%
14.29
+3.17%
13.85
Net PPE
0.92
-80.85%
4.78
-45.01%
8.69
-34.03%
13.17
Gross PPE
4.20
-62.57%
11.22
-20.45%
14.11
-20.61%
17.77
Accumulated Depreciation
-3.29
+49.01%
-6.45
-18.91%
-5.42
-17.77%
-4.60
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.18
-96.85%
5.85
+0.10%
5.84
+25.22%
4.67
Other Properties
0.75
-60.29%
1.89
-60.53%
4.78
-50.95%
9.74
Leases
3.27
-6.31%
3.49
+0.00%
3.49
+3.62%
3.37
Non Current Accounts Receivable
—
1.74
—
—
Non Current Prepaid Assets
0.00
-100.00%
0.67
-87.66%
5.46
—
Other Non Current Assets
—
—
0.13
-80.12%
0.67
Total Liabilities Net Minority Interest
6.57
-76.32%
27.77
-17.52%
33.66
+13.37%
29.70
Current Liabilities
6.57
-67.66%
20.33
+14.57%
17.74
+61.35%
11.00
Payables And Accrued Expenses
4.18
-52.85%
8.87
-19.54%
11.02
+113.15%
5.17
Payables
0.51
-86.11%
3.65
-55.75%
8.25
+232.84%
2.48
Accounts Payable
0.51
-86.11%
3.65
-55.75%
8.25
+232.84%
2.48
Current Accrued Expenses
3.67
-29.58%
5.22
+88.21%
2.77
+2.97%
2.69
Pensionand Other Post Retirement Benefit Plans Current
0.07
-97.57%
2.72
-26.75%
3.71
+13.74%
3.26
Current Debt And Capital Lease Obligation
2.33
-73.40%
8.74
+190.27%
3.01
+17.43%
2.56
Current Debt
—
5.22
—
—
Other Current Borrowings
—
5.22
—
—
Current Capital Lease Obligation
2.33
-34.03%
3.53
+17.07%
3.01
+17.43%
2.56
Other Current Liabilities
—
—
0.11
-60.00%
0.27
Total Non Current Liabilities Net Minority Interest
0.00
-100.00%
7.44
-53.29%
15.92
-14.86%
18.70
Long Term Debt And Capital Lease Obligation
0.00
-100.00%
7.44
-53.29%
15.92
-14.86%
18.70
Long Term Debt
—
5.11
-49.24%
10.07
+2.39%
9.83
Long Term Capital Lease Obligation
0.00
-100.00%
2.33
-60.25%
5.85
-33.99%
8.87
Stockholders Equity
70.07
-40.07%
116.92
-37.67%
187.57
-30.50%
269.87
Common Stock Equity
70.07
-40.07%
116.92
-37.67%
187.57
-30.50%
269.87
Capital Stock
0.01
+0.00%
0.01
+0.00%
0.01
-89.71%
0.07
Common Stock
0.01
+0.00%
0.01
+0.00%
0.01
-89.71%
0.07
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
7.33
+0.38%
7.30
+0.35%
7.28
+6.26%
6.85
Ordinary Shares Number
7.33
+0.38%
7.30
+0.35%
7.28
+6.26%
6.85
Additional Paid In Capital
560.60
+1.64%
551.57
+2.44%
538.46
+3.62%
519.62
Retained Earnings
-490.53
-12.90%
-434.50
-23.87%
-350.76
-40.93%
-248.89
Gains Losses Not Affecting Retained Earnings
0.00
+100.00%
-0.16
-24.62%
-0.13
+85.92%
-0.92
Other Equity Adjustments
—
-0.16
-24.62%
-0.13
+85.92%
-0.92
Total Equity Gross Minority Interest
70.07
-40.07%
116.92
-37.67%
187.57
-30.50%
269.87
Total Capitalization
70.07
-42.58%
122.03
-38.26%
197.64
-29.34%
279.71
Working Capital
69.16
-40.97%
117.16
-38.08%
189.21
-31.13%
274.73
Invested Capital
70.07
-44.93%
127.24
-35.62%
197.64
-29.34%
279.71
Total Debt
2.33
-85.62%
16.18
-14.54%
18.93
-10.96%
21.26
Capital Lease Obligations
2.33
-60.25%
5.85
-33.98%
8.86
-22.45%
11.43
Net Tangible Assets
70.07
-40.07%
116.92
-37.67%
187.57
-30.50%
269.87
Tangible Book Value
70.07
-40.07%
116.92
-37.67%
187.57
-30.50%
269.87
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-51.78
+30.23%
-74.21
+9.10%
-81.64
-38.74%
-58.85
Cash Flow From Continuing Operating Activities
-51.78
+30.23%
-74.21
+9.10%
-81.64
-38.74%
-58.85
Net Income From Continuing Operations
-56.03
+33.08%
-83.74
+17.80%
-101.87
-49.28%
-68.24
Depreciation Amortization Depletion
0.90
-13.75%
1.04
-2.44%
1.07
+4.20%
1.02
Depreciation And Amortization
0.90
-13.75%
1.04
-2.44%
1.07
+4.20%
1.02
Other Non Cash Items
0.47
+74.53%
0.27
+12.18%
0.24
+6.25%
0.22
Stock Based Compensation
8.96
-31.11%
13.01
-28.26%
18.14
+29.49%
14.01
Asset Impairment Charge
0.91
-41.45%
1.55
-46.73%
2.91
0.00
Operating Gains Losses
0.43
—
—
0.01
Net Foreign Currency Exchange Gain Loss
0.28
0.00
0.00
—
Gain Loss On Sale Of PPE
—
—
—
0.01
Change In Working Capital
-5.40
-315.62%
-1.30
-127.62%
4.71
+205.54%
-4.46
Change In Prepaid Assets
1.91
+469.85%
0.34
-90.65%
3.58
+161.91%
-5.79
Change In Payables And Accrued Expense
-7.34
-133.25%
-3.15
-149.57%
6.35
+249.89%
1.81
Change In Other Working Capital
-2.39
-43.14%
-1.67
-450.83%
-0.30
-222.34%
-0.09
Change In Other Current Assets
2.42
-24.06%
3.18
+164.62%
-4.92
-1155.36%
-0.39
Change In Other Current Liabilities
—
—
—
-0.09
Investing Cash Flow
92.46
+14.96%
80.43
+5.76%
76.05
+183.21%
-91.39
Cash Flow From Continuing Investing Activities
92.46
+14.96%
80.43
+5.76%
76.05
+183.21%
-91.39
Net PPE Purchase And Sale
0.11
+489.66%
-0.03
+98.39%
-1.80
-14.39%
-1.58
Purchase Of PPE
-0.01
+72.41%
-0.03
+98.40%
-1.81
-14.70%
-1.58
Sale Of PPE
0.12
0.00
-100.00%
0.01
0.00
Capital Expenditure
-0.01
+72.41%
-0.03
+98.40%
-1.81
-14.70%
-1.58
Net Investment Purchase And Sale
92.35
+14.78%
80.46
+3.35%
77.85
+186.68%
-89.81
Purchase Of Investment
-42.63
+53.33%
-91.34
+49.37%
-180.40
+45.70%
-332.20
Sale Of Investment
134.98
-21.43%
171.79
-33.48%
258.25
+6.54%
242.39
Financing Cash Flow
-10.59
-10376.70%
0.10
-83.86%
0.64
-99.50%
127.86
Cash Flow From Continuing Financing Activities
-10.59
-10376.70%
0.10
-83.86%
0.64
-99.50%
127.86
Net Issuance Payments Of Debt
-10.65
0.00
0.00
0.00
Issuance Of Debt
—
—
0.00
0.00
Repayment Of Debt
-10.65
0.00
0.00
—
Long Term Debt Issuance
—
—
0.00
0.00
Long Term Debt Payments
-10.65
0.00
0.00
—
Net Long Term Debt Issuance
-10.65
0.00
0.00
0.00
Net Common Stock Issuance
0.07
-36.89%
0.10
-83.86%
0.64
-99.50%
126.54
Proceeds From Stock Option Exercised
—
0.10
-83.86%
0.64
-51.63%
1.32
Changes In Cash
30.10
+376.36%
6.32
+227.37%
-4.96
+77.83%
-22.38
Effect Of Exchange Rate Changes
0.03
+144.44%
-0.06
-3050.00%
-0.00
+95.92%
-0.05
Beginning Cash Position
41.75
+17.63%
35.49
-12.27%
40.46
-35.66%
62.88
End Cash Position
71.88
+72.17%
41.75
+17.63%
35.49
-12.27%
40.46
Free Cash Flow
-51.78
+30.25%
-74.24
+11.04%
-83.45
-38.12%
-60.42
Interest Paid Supplemental Data
0.77
-42.62%
1.33
+1.52%
1.31
+35.15%
0.97
Amortization Of Securities
-2.00
+60.30%
-5.04
+26.16%
-6.83
-387.51%
-1.40
Common Stock Issuance
0.07
-36.89%
0.10
-83.86%
0.64
-99.50%
126.54
Issuance Of Capital Stock
0.07
-36.89%
0.10
-83.86%
0.64
-99.50%
126.54
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category